Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 16 at 2:00 PM EDT

Register Free →

Drug Repurposing Accelerator and Regulatory Roadmap

Active
Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The Drug Repurposing Accelerator and Regulatory Roadmap subcontract, managed by the FDA Negotiated Contracts Branch within the Department of Health and Human Services, focuses on developing a regulatory pathway for drug repurposing. The selected contractor will organize and facilitate approximately 11 virtual biweekly expert meetings for prime contractors, requiring a high level of expertise in FDA regulatory approval processes. Key deliverables include the preparation of public meeting summaries for the RUF website, a comprehensive final synthesis report of identified themes, and the publication of a Regulatory Roadmap. The performance of these services is centered in Silver Spring, Maryland, under NAICS code 541611.

General Info

FDA subcontract to develop a drug repurposing regulatory roadmap via expert virtual meetings.

Agency

Department Of Health And Human Services → FDA Negotiated Contracts BranchView Agency

NAICS

541611 - Administrative Management and General Management Consulting ServicesView NAICS

Place of Performance

Silver Spring, MD, 20993, USA

Set-Aside

NONE

Documents

This scope was carved out of FDASSOC136354.

The full solicitation package (2 documents), including the RFP, is on the prime solicitation, not on this scope.

View the prime solicitation

The Food and Drug Administration (FDA) intends to award a sole source contract to the Reagan-Udall Foundation for the FDA (RUF) to support execution of its ts congressionally mandated regulatory mission across 16 project areas

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

Posted

subcontract

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → FDA Negotiated Contracts Branch
ContactsNo contacts available
OfficeN/A
Organization / Agency
Department Of Health And Human Services → FDA Negotiated Contracts Branch
View Agency Profile
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
Convenes expert meetings for prime contractors on FDA projects to develop a regulatory pathway for drug repurposing. Manages approximately 11 virtual biweekly meetings, prepares public meeting summaries for the RUF website, and synthesizes themes into a final report. Requires deep knowledge of FDA regulatory pathways for drug approval. Delivers meeting summaries, a final synthesis report, and a published Regulatory Roadmap.

Similar Contracts

Same NAICS industry code

More opportunities from Department Of Health And Human Services → FDA Negotiated Contracts Branch

Same awarding agency

NAICS: 541618
New
Federal
The Food and Drug Administration (FDA) intends to award a sole source contract to the Reagan-Udall Foundation for the FDA (RUF) to support execution of its ts congressionally mandated regulatory mission across 16 project areas
Solicitation # FDASSOC136354
The Food and Drug Administration intends to award a firm fixed price sole source contract to the Reagan-Udall Foundation for the FDA (RUF) for the period of September 30, 2026, through September 29, 2027. This engagement is designed to support the FDA's congressionally mandated regulatory mission across 16 project areas, utilizing the Pathways for Regulatory Innovation and Strategic Modernization (PRISM) framework. The scope of work includes independent stakeholder convening, scientific engagement, operational evaluation, and landscape research to address critical regulatory science gaps and public health challenges. Key focus areas include emerging neurotechnologies, rare disease diagnostics, real-world evidence for medical devices, generic drug quality, cosmetovigilance under MoCRA, food inspection modernization, and nicotine use disorder treatment. The RUF will operate as an independent private nonprofit partner and is strictly prohibited from participating in FDA regulatory decision-making or providing advice on specific regulatory policy matters. Deliverables include publicly available or agency-facing reports, white papers, and the facilitation of workshops and expert panels. All work must adhere to strict cybersecurity standards, including NIST SP 800-53 or 800-171, and comply with Executive Order 13556 regarding controlled unclassified information. The contract is justified as a sole source based on the foundation's statutory mandate under the FDAAA of 2007. Performance will take place at the contractor's facility, with the FDA's Contracting Officer's Representative overseeing the inspection and acceptance of all deliverables.
Other Management Consulting Services

POSTED

about 14 hours ago

DEADLINE

in 7 days
View Details

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 650+ contractors already using CLEATUS